Health News Releases

January 27, 2020 11:40

Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos

Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World

January 27, 2020 11:33

President Bill Clinton to Keynote 2020 World Patient Safety, Science & Technology Summit

President Bill Clinton, the 42nd President of the United States, will be the closing keynote speaker at the Patient Safety Movement Foundation’s 2020 World Patient Safety, Science & Technology Summit.

January 22, 2020 16:00

PDC*line Pharma Raises €20 Million in Series B Financing Round

PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today the completion of its Series B round of financing. T

January 22, 2020 11:35

Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named in the Corporate Knights Global 100 Most Sustainable Corporations in the World (Global 100) for the fifth co

January 22, 2020 09:42

OncoSec Sends Letter Urging Shareholders Not to Be Distracted by Alpha’s Last-Ditch Efforts to Derail CGP/Sirtex Transaction

Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareh

January 21, 2020 13:34

GeneMedicine Appoints MIT Professor Robert S. Langer, Sc.D to Its Scientific Advisory Board

GeneMedicine Co., Ltd., a leader in the field of oncolytic adenovirus platform for the treatment of intractable cancers, announced that the company has appointed Robert S. Langer, Sc.D., the David H.

January 21, 2020 10:41

Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan

Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ bi

January 20, 2020 23:00

ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. Full face CPAP users can no

January 20, 2020 10:37

Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness

The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Ey

January 17, 2020 08:44

OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the “Board”)

January 16, 2020 09:50

AMR Life Science Industry 2020 Report: Successes and Setbacks in Fighting Superbugs

AMR Industry Alliance report released today provides a unique snapshot of the life science industry’s collective efforts in delivering on their commitments to tackle the rise of antimicrobial resistan

January 15, 2020 15:11

Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthc

January 15, 2020 13:49

Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Hes

January 15, 2020 09:06

GNT Pharma‘s Anti-dementia Drug ’crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia

GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. In the clinical study cond

January 14, 2020 11:45

BLEED OUT Documentary Screening and Panel Discussion

Patient Safety Movement Foundation: WHAT: After a routine partial hip replacement operation leaves his mother in a coma with permanent brain damage, a son’s video diary becomes a citizen’s inves

January 14, 2020 08:58

Study Shows HK L-137 Reduces Inflammation in Healthy Overweight Individuals — Takes Front Line Against Metabolic Syndrome

There’s a reason why the health-conscious focus has turned toward foods, supplements and behaviors to reduce inflammation. It’s why House Wellness Foods has put decades of meticulous research into the

January 13, 2020 09:35

Terns Pharmaceuticals Presents Results From An Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced the

January 10, 2020 09:45

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of Ind

January 10, 2020 08:38

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced today the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelhe

January 09, 2020 13:39

Covetrus Announces Changes to Senior Management Team

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced several changes to its senior management and regional leadership teams. Effective January 7, 2020

January 09, 2020 11:50

Patient Safety Movement Foundation Launches ifyouvebeenharmed Website

Now there’s a website for patients and families that have experienced harm from medical errors: ifyouvebeenharmed.org. Launched by the Patient Safety Movement Foundation (PSMF), the site provides reso

January 08, 2020 16:50

Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TOKYO: 6701), a leader in IT and network

January 07, 2020 10:30

OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms - ISS and Glass Lewis - Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE Proxy Card

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to its shareholders. Th

December 31, 2019 11:48

WELT Smart Belt Pro Wins CES 2020 Innovation Award

WELT, a digital healthcare company, won the Innovation Awards for its new product, Smart Belt Pro, at CES 2020, the world’s largest consumer appliance fair, which is held in January 2020. An update

December 27, 2019 09:41

Institutional Shareholder Services Inc. (“ISS”) Recommends OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Institutional Shareholder Services I

News by Region

News by Industry